Motif ID: Foxj3_Tbl1xr1
Z-value: 1.237
Transcription factors associated with Foxj3_Tbl1xr1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Foxj3 | ENSMUSG00000032998.10 | Foxj3 |
| Tbl1xr1 | ENSMUSG00000027630.8 | Tbl1xr1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Foxj3 | mm10_v2_chr4_+_119539652_119539698 | 0.18 | 1.2e-01 | Click! |
| Tbl1xr1 | mm10_v2_chr3_+_22076644_22076681 | 0.04 | 7.2e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 8.4 | GO:0090425 | hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 2.5 | 10.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 2.0 | 12.0 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 2.0 | 3.9 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 2.0 | 31.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 1.8 | 7.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.6 | 4.8 | GO:0030421 | defecation(GO:0030421) |
| 1.6 | 4.7 | GO:0070671 | response to interleukin-12(GO:0070671) |
| 1.6 | 7.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 1.5 | 5.9 | GO:0060032 | notochord regression(GO:0060032) |
| 1.4 | 4.3 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 1.4 | 7.2 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 1.4 | 4.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 1.3 | 4.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.3 | 5.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 1.3 | 3.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.3 | 6.4 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 1.3 | 7.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 1.2 | 3.7 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.2 | 6.1 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.2 | 4.6 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
| 1.1 | 4.5 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.1 | 3.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 1.1 | 4.4 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 1.1 | 6.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 1.0 | 1.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
| 1.0 | 5.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 1.0 | 3.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 1.0 | 5.0 | GO:1902623 | negative regulation of neutrophil migration(GO:1902623) |
| 1.0 | 4.0 | GO:0070269 | pyroptosis(GO:0070269) |
| 1.0 | 4.9 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 1.0 | 1.9 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.9 | 2.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.9 | 5.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.9 | 7.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.9 | 4.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.9 | 1.8 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.9 | 10.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.9 | 2.6 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.9 | 0.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.8 | 2.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.8 | 4.0 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.8 | 3.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.8 | 2.4 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.8 | 2.4 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.8 | 3.9 | GO:0051309 | female meiosis chromosome separation(GO:0051309) |
| 0.8 | 2.3 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
| 0.8 | 6.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.8 | 3.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.8 | 2.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.8 | 1.5 | GO:1902022 | L-lysine transport(GO:1902022) |
| 0.8 | 2.3 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.8 | 9.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.7 | 0.7 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.7 | 7.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.7 | 3.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.7 | 2.2 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.7 | 2.2 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
| 0.7 | 3.6 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.7 | 2.2 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.7 | 2.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.7 | 0.7 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.7 | 4.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.7 | 2.0 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 0.7 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.7 | 0.7 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
| 0.7 | 3.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.7 | 2.0 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.7 | 11.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.7 | 10.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.7 | 2.6 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.7 | 2.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.7 | 2.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.6 | 0.6 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 0.6 | 1.9 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.6 | 3.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.6 | 4.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.6 | 2.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.6 | 1.2 | GO:0060023 | soft palate development(GO:0060023) |
| 0.6 | 5.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.6 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.6 | 1.8 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
| 0.6 | 1.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.6 | 0.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.6 | 3.0 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.6 | 1.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.6 | 2.4 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.6 | 4.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.6 | 2.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.6 | 0.6 | GO:0033083 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) |
| 0.6 | 2.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.6 | 3.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.6 | 1.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.6 | 1.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.6 | 0.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.6 | 2.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
| 0.6 | 6.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.6 | 1.1 | GO:2000790 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.6 | 1.7 | GO:0045004 | DNA replication proofreading(GO:0045004) |
| 0.6 | 1.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.6 | 1.7 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.6 | 1.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.5 | 1.6 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.5 | 2.2 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
| 0.5 | 2.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.5 | 1.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 0.5 | 1.1 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.5 | 3.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.5 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.5 | 2.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.5 | 1.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 0.5 | 1.6 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.5 | 1.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.5 | 0.5 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.5 | 1.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.5 | 1.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.5 | 3.5 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.5 | 7.1 | GO:0072189 | ureter development(GO:0072189) |
| 0.5 | 20.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.5 | 1.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 | 1.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
| 0.5 | 4.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.5 | 1.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.5 | 3.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.5 | 0.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.5 | 5.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.5 | 3.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.5 | 1.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.5 | 2.5 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
| 0.5 | 3.0 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.5 | 1.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 | 2.4 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.5 | 0.5 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.5 | 3.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.5 | 5.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.5 | 1.4 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.5 | 2.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.5 | 1.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.5 | 1.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.5 | 5.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.5 | 2.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 | 0.9 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.5 | 5.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.5 | 0.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.5 | 5.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.5 | 0.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.5 | 2.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.5 | 1.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.5 | 1.4 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.5 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.5 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.5 | 1.8 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.5 | 1.4 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.4 | 10.3 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.4 | 0.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.4 | 4.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.4 | 2.7 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.4 | 2.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.4 | 4.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.4 | 1.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.4 | 1.3 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.4 | 0.4 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.4 | 2.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.4 | 2.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.4 | 0.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.4 | 3.0 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
| 0.4 | 1.3 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.4 | 4.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.4 | 2.1 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.4 | 3.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.4 | 4.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.4 | 0.4 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.4 | 0.8 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.4 | 3.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.4 | 4.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.4 | 3.3 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.4 | 0.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.4 | 7.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.4 | 2.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.4 | 0.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.4 | 0.4 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.4 | 2.4 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.4 | 3.6 | GO:1900225 | NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
| 0.4 | 3.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.4 | 0.8 | GO:0009597 | detection of virus(GO:0009597) |
| 0.4 | 1.6 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
| 0.4 | 1.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 | 5.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.4 | 1.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 | 1.5 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.4 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.4 | 1.5 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.4 | 1.5 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.4 | 3.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 | 1.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.4 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.4 | 1.9 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.4 | 0.4 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.4 | 6.0 | GO:0007379 | segment specification(GO:0007379) |
| 0.4 | 1.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.4 | 2.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.4 | 2.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.4 | 3.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.4 | 1.5 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.4 | 3.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.4 | 0.7 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.4 | 1.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 1.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.4 | 3.0 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.4 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.4 | 1.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.4 | 0.4 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.4 | 1.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.4 | 1.1 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.4 | 1.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
| 0.4 | 1.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.4 | 1.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.4 | 2.5 | GO:0043586 | tongue development(GO:0043586) |
| 0.4 | 0.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.4 | 0.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.4 | 1.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.4 | 2.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.4 | 1.1 | GO:0030862 | neuroblast division in subventricular zone(GO:0021849) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.4 | 2.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.4 | 1.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.3 | 5.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.3 | 2.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.3 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.3 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.3 | 1.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.3 | 1.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.3 | 2.1 | GO:0015791 | polyol transport(GO:0015791) |
| 0.3 | 2.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.3 | 2.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 0.3 | 1.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.3 | 3.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.3 | 5.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 | 1.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.3 | 2.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.3 | 3.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.3 | 2.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.3 | 1.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.3 | 2.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.3 | 0.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.3 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 1.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.3 | 1.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.3 | 1.6 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.3 | 3.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.3 | 1.0 | GO:0035989 | tendon development(GO:0035989) |
| 0.3 | 4.9 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
| 0.3 | 0.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
| 0.3 | 8.8 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.3 | 1.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.3 | 1.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.3 | 0.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.3 | 1.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.3 | 2.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.3 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.3 | 1.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.3 | 2.2 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.3 | 0.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
| 0.3 | 1.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.3 | 1.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.3 | 0.3 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.3 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.3 | 0.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.3 | 6.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.3 | 1.9 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.3 | 0.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.3 | 7.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.3 | 0.6 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
| 0.3 | 0.9 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.3 | 2.8 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.3 | 0.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.3 | 0.9 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.3 | 1.2 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.3 | 1.2 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
| 0.3 | 0.6 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.3 | 0.9 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.3 | 1.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.3 | 1.8 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.3 | 1.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.3 | 1.2 | GO:0090472 | dibasic protein processing(GO:0090472) |
| 0.3 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.3 | 1.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.3 | 0.6 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.3 | 2.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.3 | 4.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.3 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
| 0.3 | 1.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.3 | 0.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.3 | 1.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.3 | 0.9 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.3 | 0.3 | GO:1905076 | regulation of interleukin-17 secretion(GO:1905076) |
| 0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.3 | 1.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.3 | 0.8 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.3 | 1.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.3 | 1.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.3 | 0.3 | GO:0046959 | habituation(GO:0046959) |
| 0.3 | 0.3 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
| 0.3 | 1.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.3 | 0.8 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.3 | 1.9 | GO:0030242 | pexophagy(GO:0030242) |
| 0.3 | 0.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.3 | 1.6 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.3 | 0.8 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.3 | 1.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 | 1.9 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.3 | 0.8 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
| 0.3 | 3.7 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.3 | 1.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.3 | 0.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 | 1.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.3 | 0.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.3 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.3 | 1.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.3 | 2.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.3 | 0.3 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.3 | 0.3 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.3 | 0.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.3 | 0.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
| 0.3 | 2.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.3 | 3.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.3 | 2.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.3 | 7.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.3 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.3 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.3 | 1.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
| 0.3 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 | 1.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.2 | 1.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.2 | 1.0 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
| 0.2 | 1.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.2 | 1.0 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.2 | 0.7 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.2 | 1.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 | 1.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.2 | 1.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.2 | 1.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.2 | 5.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.2 | 3.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 2.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
| 0.2 | 0.7 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 | 0.2 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.2 | 2.8 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.2 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 0.2 | GO:0003195 | tricuspid valve formation(GO:0003195) |
| 0.2 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.2 | 2.5 | GO:0060013 | righting reflex(GO:0060013) |
| 0.2 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.2 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.2 | 0.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
| 0.2 | 0.7 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.2 | 3.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 | 0.9 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.2 | 0.2 | GO:0048793 | pronephros development(GO:0048793) |
| 0.2 | 2.5 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.2 | 1.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.2 | 2.7 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.2 | 0.7 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.2 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 3.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.2 | 1.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.2 | 0.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.2 | 0.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.2 | 0.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 | 1.3 | GO:0035878 | nail development(GO:0035878) |
| 0.2 | 0.2 | GO:0098705 | plasma membrane copper ion transport(GO:0015679) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
| 0.2 | 1.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.2 | 2.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.2 | 0.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 | 0.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.2 | 0.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.2 | 0.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 | 0.6 | GO:0070602 | regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.2 | 1.5 | GO:0002360 | T cell lineage commitment(GO:0002360) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.2 | 0.4 | GO:0002423 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
| 0.2 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 0.6 | GO:1990046 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.2 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.2 | 1.9 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.2 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.2 | 0.6 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 0.6 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.2 | 0.4 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
| 0.2 | 2.7 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.2 | 1.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.2 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.2 | 2.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 2.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 | 2.1 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.2 | 0.8 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 | 0.8 | GO:0046078 | dUMP metabolic process(GO:0046078) |
| 0.2 | 2.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 | 1.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.2 | 0.8 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.2 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.2 | 1.4 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
| 0.2 | 1.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.2 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.2 | 0.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.2 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
| 0.2 | 0.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 5.2 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.2 | 2.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.2 | 0.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.2 | 0.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
| 0.2 | 0.6 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 0.2 | 5.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.2 | 0.6 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
| 0.2 | 0.6 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 | 1.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 0.8 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.2 | 0.6 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
| 0.2 | 0.6 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.2 | 1.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.2 | 0.6 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
| 0.2 | 0.6 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.2 | 2.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 | 0.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 | 0.9 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) mast cell migration(GO:0097531) |
| 0.2 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
| 0.2 | 0.9 | GO:0060631 | regulation of meiosis I(GO:0060631) |
| 0.2 | 2.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.2 | 5.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.2 | 1.8 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.2 | 0.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 0.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.2 | 3.6 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.2 | 1.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.2 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.2 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 3.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 | 0.7 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.2 | 0.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.2 | 3.0 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.2 | 0.7 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
| 0.2 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.2 | 0.3 | GO:1905154 | negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 0.2 | 0.5 | GO:0007320 | insemination(GO:0007320) |
| 0.2 | 0.7 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 | 0.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.2 | 0.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 | 0.7 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.2 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 | 0.5 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.2 | 1.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.2 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.2 | 3.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.2 | 1.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 | 2.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.2 | 1.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 3.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 | 0.5 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.2 | 1.0 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 1.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 0.5 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.2 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.2 | 0.8 | GO:1990839 | response to endothelin(GO:1990839) |
| 0.2 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 | 1.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.2 | 0.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 0.3 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
| 0.2 | 1.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.2 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 | 2.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 | 3.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.2 | 0.3 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 | 0.2 | GO:1900133 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.2 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 | 1.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 1.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 | 0.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.2 | 0.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 | 0.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.2 | 0.3 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.2 | 3.1 | GO:0098534 | centriole assembly(GO:0098534) |
| 0.2 | 0.5 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 | 1.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.2 | 0.9 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.2 | 0.5 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
| 0.2 | 2.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 | 0.8 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.2 | 0.3 | GO:0045006 | DNA deamination(GO:0045006) |
| 0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.2 | 1.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 | 1.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
| 0.2 | 0.6 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.2 | 0.3 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
| 0.1 | 0.3 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
| 0.1 | 0.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 | 2.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 0.1 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
| 0.1 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 1.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.1 | 0.7 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 0.7 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 | 0.9 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.4 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.1 | 4.4 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.1 | 0.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 3.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.1 | 0.6 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 1.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 2.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 | 1.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
| 0.1 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 0.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 | 0.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 0.7 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 3.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.3 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 | 0.3 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 | 2.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.1 | 0.5 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
| 0.1 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
| 0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
| 0.1 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.1 | 0.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.1 | 0.3 | GO:0050912 | detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 1.6 | GO:0097502 | mannosylation(GO:0097502) |
| 0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
| 0.1 | 1.3 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.6 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 | 0.3 | GO:1904059 | regulation of eating behavior(GO:1903998) regulation of locomotor rhythm(GO:1904059) |
| 0.1 | 0.9 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
| 0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 | 1.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.9 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) skeletal muscle cell proliferation(GO:0014856) |
| 0.1 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 0.4 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.1 | 1.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 1.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 3.5 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 1.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.1 | 0.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 0.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 8.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.1 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 0.1 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
| 0.1 | 0.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 | 0.2 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.1 | 0.1 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 | 1.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.1 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 | 1.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.1 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 0.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 | 1.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.1 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 0.3 | GO:0006586 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) aromatic amino acid family catabolic process(GO:0009074) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 | 0.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 | 0.3 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 0.4 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 | 1.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 0.3 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.1 | 0.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 0.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 1.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 1.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 1.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 1.5 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
| 0.1 | 0.1 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.2 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 | 0.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 | 0.7 | GO:0015862 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.1 | 0.1 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 | 0.7 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.1 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 | 0.1 | GO:1990743 | protein sialylation(GO:1990743) |
| 0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.1 | 0.2 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.1 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 | 0.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 | 1.4 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 | 5.1 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.1 | 0.9 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 | 0.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.1 | 0.1 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
| 0.1 | 1.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.1 | 2.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 0.6 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.1 | 0.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 | 0.2 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
| 0.1 | 0.6 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.1 | 0.6 | GO:0035826 | rubidium ion transport(GO:0035826) |
| 0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.6 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
| 0.1 | 1.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 2.5 | GO:0009268 | response to pH(GO:0009268) |
| 0.1 | 0.4 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 1.5 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 | 1.9 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.1 | 0.3 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 | 0.9 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.1 | 4.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.1 | 0.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 | 0.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.1 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.4 | GO:0072362 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 0.1 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 1.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.1 | 2.2 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
| 0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 0.7 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.1 | 0.2 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.1 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.2 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.1 | 2.0 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 0.4 | GO:0051299 | mitotic centrosome separation(GO:0007100) centrosome separation(GO:0051299) |
| 0.1 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 | 0.2 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.1 | 0.2 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.1 | 0.6 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 0.1 | 3.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 1.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 | 0.4 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
| 0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.1 | 0.2 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
| 0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.1 | 0.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 | 0.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.1 | 0.2 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.1 | 0.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 0.1 | 0.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.1 | 0.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 0.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.1 | 2.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.1 | 0.1 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 | 1.5 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.1 | 0.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.1 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.8 | GO:0045056 | transcytosis(GO:0045056) |
| 0.1 | 0.5 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 | 0.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 1.2 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.1 | 0.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
| 0.1 | 0.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 1.4 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.1 | 0.3 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 0.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.1 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 0.1 | 0.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
| 0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.2 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 0.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.1 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
| 0.1 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 | 0.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.1 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
| 0.1 | 0.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.1 | 0.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
| 0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 0.6 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.1 | 0.2 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.4 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 0.6 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 0.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 | 0.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 0.6 | GO:0035384 | acetyl-CoA biosynthetic process(GO:0006085) thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.1 | 0.1 | GO:0002891 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
| 0.1 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.8 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.1 | 0.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.1 | 0.5 | GO:0007569 | cell aging(GO:0007569) |
| 0.1 | 0.1 | GO:0034773 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.2 | GO:0045852 | lysosomal lumen pH elevation(GO:0035752) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 | 0.7 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.1 | 0.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.1 | 0.1 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.1 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.3 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.1 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.1 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.2 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.0 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 0.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.1 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
| 0.0 | 0.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.0 | 0.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 | 0.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 0.0 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.0 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.0 | 0.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.0 | 1.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.5 | GO:0051647 | nucleus localization(GO:0051647) |
| 0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 | 0.2 | GO:0061205 | paramesonephric duct development(GO:0061205) |
| 0.0 | 1.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 | 1.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.1 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.0 | 0.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 | 0.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.4 | GO:0032608 | interferon-beta production(GO:0032608) |
| 0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 0.4 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.0 | 0.8 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.0 | 0.0 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.0 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 1.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.0 | 0.8 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 0.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.0 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.0 | 1.7 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.0 | 0.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.0 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 0.8 | GO:0007098 | centrosome cycle(GO:0007098) |
| 0.0 | 1.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.0 | 1.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.0 | 0.9 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 | 1.9 | GO:0000910 | cytokinesis(GO:0000910) |
| 0.0 | 0.6 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 | 0.1 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.0 | 0.1 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.0 | 0.2 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
| 0.0 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.0 | 0.9 | GO:0090659 | walking behavior(GO:0090659) |
| 0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.2 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 | 0.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.2 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
| 0.0 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 | 0.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.0 | 0.5 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.0 | 0.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.0 | 0.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 | 0.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.0 | 0.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.0 | 0.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.0 | 0.1 | GO:0044532 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
| 0.0 | 0.0 | GO:0060594 | mammary gland formation(GO:0060592) mammary gland specification(GO:0060594) |
| 0.0 | 0.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 | 0.2 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 | 0.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
| 0.0 | 0.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 | 0.1 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
| 0.0 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
| 0.0 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
| 0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.0 | 0.0 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
| 0.0 | 0.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 | 0.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 | 0.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 | 0.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.1 | GO:0033143 | androgen receptor signaling pathway(GO:0030521) regulation of intracellular steroid hormone receptor signaling pathway(GO:0033143) regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 | 0.3 | GO:0035194 | posttranscriptional gene silencing(GO:0016441) posttranscriptional gene silencing by RNA(GO:0035194) |
| 0.0 | 0.5 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.0 | 0.0 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
| 0.0 | 0.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 | 0.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.0 | 0.0 | GO:0072683 | T cell extravasation(GO:0072683) |
| 0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 | 0.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.0 | 0.0 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 7.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.8 | 5.5 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 1.7 | 10.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 1.2 | 13.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 1.1 | 5.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 1.0 | 4.1 | GO:0061702 | inflammasome complex(GO:0061702) |
| 1.0 | 3.1 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
| 1.0 | 9.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.9 | 4.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.8 | 2.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.8 | 7.5 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.8 | 1.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.8 | 3.1 | GO:0008623 | CHRAC(GO:0008623) |
| 0.8 | 2.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.8 | 2.3 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.7 | 2.1 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.7 | 10.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.7 | 2.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.7 | 2.6 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.6 | 1.9 | GO:0071914 | prominosome(GO:0071914) |
| 0.6 | 3.8 | GO:0098536 | deuterosome(GO:0098536) |
| 0.6 | 3.1 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.6 | 2.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.6 | 7.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.6 | 1.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.6 | 1.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.6 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.6 | 3.9 | GO:0000796 | condensin complex(GO:0000796) |
| 0.5 | 3.2 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.5 | 2.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.5 | 5.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.5 | 3.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.5 | 4.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.5 | 2.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.5 | 3.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.5 | 2.5 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.5 | 1.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.5 | 1.9 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.5 | 12.8 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.5 | 5.9 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.4 | 1.3 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
| 0.4 | 6.8 | GO:0036038 | MKS complex(GO:0036038) |
| 0.4 | 2.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.4 | 2.1 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.4 | 4.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.4 | 3.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.4 | 1.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.4 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.4 | 1.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.4 | 1.1 | GO:0002177 | manchette(GO:0002177) |
| 0.4 | 4.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.4 | 1.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.4 | 7.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.4 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.4 | 1.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.4 | 1.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.3 | 1.0 | GO:0031251 | PAN complex(GO:0031251) |
| 0.3 | 2.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.3 | 1.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 6.0 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.3 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.3 | 1.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.3 | 4.9 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.3 | 0.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
| 0.3 | 5.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.3 | 1.8 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.3 | 2.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 2.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.3 | 4.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.3 | 1.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.3 | 4.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.3 | 0.9 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.3 | 2.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.3 | 2.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.3 | 0.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.3 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.3 | 1.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 16.7 | GO:0016459 | myosin complex(GO:0016459) |
| 0.3 | 0.8 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 0.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.3 | 1.3 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.3 | 1.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.3 | 1.1 | GO:0043293 | apoptosome(GO:0043293) |
| 0.3 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.3 | 7.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.2 | 3.2 | GO:0042581 | specific granule(GO:0042581) |
| 0.2 | 1.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 3.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 2.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 0.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.2 | 1.2 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.2 | 1.9 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.2 | 4.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 2.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
| 0.2 | 3.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.2 | 0.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
| 0.2 | 0.6 | GO:0071920 | cleavage body(GO:0071920) |
| 0.2 | 0.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.2 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.2 | 2.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.2 | 0.8 | GO:0060187 | cell pole(GO:0060187) |
| 0.2 | 5.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.2 | 2.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.2 | 1.2 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.2 | 1.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 2.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.2 | 2.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.2 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
| 0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 4.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 0.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.2 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 0.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.2 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 5.0 | GO:0005657 | replication fork(GO:0005657) |
| 0.2 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.2 | 4.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 0.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.2 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.2 | 1.8 | GO:0048500 | signal recognition particle(GO:0048500) |
| 0.2 | 0.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 14.7 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 8.1 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.2 | 3.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.2 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.2 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
| 0.2 | 0.8 | GO:1990462 | omegasome(GO:1990462) |
| 0.2 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.2 | 7.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.2 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.2 | 6.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 2.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 1.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.2 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
| 0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 0.1 | GO:0005940 | septin ring(GO:0005940) |
| 0.1 | 0.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.1 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.3 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.1 | 4.3 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.1 | 0.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
| 0.1 | 1.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.7 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 1.4 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 3.9 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 1.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 1.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 2.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.1 | 1.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 4.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.5 | GO:0034358 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
| 0.1 | 1.1 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 3.1 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 0.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 14.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 2.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 4.4 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 1.0 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.2 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 0.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 1.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 14.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.1 | 1.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
| 0.1 | 0.2 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.1 | 1.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 4.4 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.1 | 4.6 | GO:0030017 | sarcomere(GO:0030017) |
| 0.1 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 5.3 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 1.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 0.9 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 0.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.3 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.1 | 0.9 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 0.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.1 | 1.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 1.1 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 0.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 0.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.1 | 5.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.1 | 1.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.1 | 0.6 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 0.2 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
| 0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
| 0.1 | 0.7 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 1.4 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 11.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.3 | GO:0044447 | axoneme part(GO:0044447) |
| 0.1 | 1.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 1.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 2.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.2 | GO:0030684 | preribosome(GO:0030684) |
| 0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 0.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 1.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 8.1 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.1 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 2.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 0.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.1 | 2.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 0.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.1 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.1 | 0.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.1 | 1.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 3.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.1 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
| 0.1 | 0.8 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
| 0.1 | 3.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 10.9 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 0.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
| 0.1 | 0.3 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 0.1 | 0.4 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.1 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.1 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 1.4 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.0 | 3.1 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.0 | 1.7 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 1.5 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.1 | GO:0071953 | fibrinogen complex(GO:0005577) elastic fiber(GO:0071953) |
| 0.0 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.7 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 1.6 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.0 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 0.0 | GO:0030677 | ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
| 0.0 | 1.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 2.6 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.0 | 0.3 | GO:0045275 | respiratory chain complex III(GO:0045275) |
| 0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.0 | 0.2 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.0 | 0.0 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.0 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 1.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 2.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 1.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 3.9 | GO:0005694 | chromosome(GO:0005694) |
| 0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.0 | 0.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.0 | 0.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.0 | 0.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 0.4 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 26.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 3.0 | 12.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 2.2 | 6.7 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 2.0 | 5.9 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
| 1.8 | 5.4 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 1.5 | 6.0 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 1.5 | 7.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 1.4 | 5.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 1.4 | 5.5 | GO:0050436 | microfibril binding(GO:0050436) |
| 1.3 | 4.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 1.3 | 7.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 1.2 | 4.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 1.2 | 5.9 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.2 | 3.5 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
| 1.1 | 9.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 1.1 | 4.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 1.1 | 3.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.9 | 2.8 | GO:0001729 | ceramide kinase activity(GO:0001729) |
| 0.9 | 6.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.9 | 5.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.9 | 6.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.9 | 5.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.8 | 2.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.8 | 9.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.8 | 4.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.8 | 2.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.8 | 4.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.8 | 19.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.8 | 2.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.8 | 3.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.8 | 3.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 0.7 | 3.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.7 | 2.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.7 | 2.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.7 | 5.7 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.7 | 8.5 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.7 | 2.6 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
| 0.7 | 2.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.6 | 0.6 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.6 | 3.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.6 | 1.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.6 | 2.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.6 | 4.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.6 | 3.1 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.6 | 2.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.6 | 2.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.6 | 1.8 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.6 | 4.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.6 | 1.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.6 | 1.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.6 | 6.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.6 | 3.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.6 | 2.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.6 | 4.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.6 | 4.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.5 | 0.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.5 | 2.2 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
| 0.5 | 3.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.5 | 1.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.5 | 3.2 | GO:0070728 | leucine binding(GO:0070728) |
| 0.5 | 9.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.5 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.5 | 2.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.5 | 2.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.5 | 1.5 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.5 | 1.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.5 | 3.1 | GO:0019841 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
| 0.5 | 1.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.5 | 1.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.5 | 1.5 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.5 | 1.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.5 | 4.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.5 | 10.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.5 | 1.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.5 | 3.3 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.5 | 1.9 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.5 | 3.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.4 | 6.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.4 | 1.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 2.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.4 | 3.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.4 | 1.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.4 | 2.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.4 | 2.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.4 | 7.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.4 | 1.2 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.4 | 1.6 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.4 | 0.8 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.4 | 1.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.4 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.4 | 3.1 | GO:0043559 | insulin binding(GO:0043559) |
| 0.4 | 1.2 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
| 0.4 | 1.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.4 | 0.4 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.4 | 1.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.4 | 3.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.4 | 1.1 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
| 0.4 | 1.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.4 | 1.1 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
| 0.4 | 0.8 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 0.4 | 0.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
| 0.4 | 1.1 | GO:0005118 | sevenless binding(GO:0005118) |
| 0.4 | 1.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.4 | 2.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.4 | 1.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.4 | 1.8 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.4 | 1.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.4 | 1.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 1.1 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.4 | 1.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.4 | 6.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.4 | 3.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.4 | 9.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.3 | 1.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.3 | 6.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 1.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 2.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.3 | 2.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.3 | 1.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.3 | 0.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.3 | 12.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.3 | 1.0 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.3 | 1.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.3 | 2.3 | GO:0001848 | complement binding(GO:0001848) |
| 0.3 | 2.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.3 | 7.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 1.0 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.3 | 2.3 | GO:0046790 | virion binding(GO:0046790) |
| 0.3 | 0.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.3 | 1.0 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.3 | 1.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.3 | 0.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.3 | 1.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.3 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.3 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.3 | 1.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.3 | 4.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.3 | 0.9 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.3 | 1.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.3 | 0.9 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.3 | 0.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 2.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.3 | 1.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.3 | 0.9 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.3 | 0.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.3 | 1.2 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.3 | 1.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.3 | 9.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.3 | 1.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 0.3 | 7.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.3 | 1.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.3 | 1.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.3 | 1.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.3 | 2.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.3 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.3 | 0.9 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.3 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.3 | 2.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.3 | 1.4 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.3 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.3 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.3 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.3 | 1.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 2.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.3 | 1.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.3 | 2.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.3 | 3.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.3 | 0.8 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.3 | 1.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.3 | 2.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.3 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.3 | 1.0 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.3 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.3 | 4.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.2 | 1.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.2 | 1.5 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.2 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 1.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.2 | 1.0 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.2 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.2 | 3.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 4.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.2 | 1.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 1.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.2 | 0.2 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.2 | 2.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.2 | 3.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.2 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.2 | 0.9 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.2 | 3.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
| 0.2 | 0.6 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
| 0.2 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 2.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.2 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.2 | 0.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.2 | 1.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.2 | 0.6 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.2 | 0.8 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.2 | 1.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.2 | 3.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
| 0.2 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
| 0.2 | 0.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.2 | 1.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.2 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.2 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.2 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.2 | 33.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.2 | 1.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.2 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.2 | 1.3 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 0.9 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 0.2 | 2.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 3.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 0.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.2 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.2 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.2 | 0.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.2 | 0.9 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.2 | 0.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.2 | 0.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
| 0.2 | 1.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
| 0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 1.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 3.8 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
| 0.2 | 1.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.2 | 1.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.2 | 1.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.2 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.2 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 0.5 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.2 | 19.8 | GO:0003774 | motor activity(GO:0003774) |
| 0.2 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.2 | 2.0 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.2 | 1.6 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.2 | 0.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 0.2 | 2.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 1.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.2 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 2.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 2.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 2.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.2 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 1.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 1.0 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 0.4 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.1 | 1.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 0.4 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.1 | 1.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 1.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.1 | 0.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.1 | 0.7 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.1 | 0.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 1.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.1 | 1.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 1.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.1 | 0.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.1 | 1.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 1.3 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 4.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 1.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 2.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.4 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.1 | 1.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 2.3 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 1.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
| 0.1 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 1.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.1 | 0.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.1 | 1.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.1 | 0.8 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.1 | 1.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 1.5 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
| 0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 1.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.1 | 0.3 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.1 | 1.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.1 | 0.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 3.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.3 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.1 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.1 | 1.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
| 0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 2.7 | GO:0042805 | actinin binding(GO:0042805) |
| 0.1 | 0.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.1 | 2.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.1 | 0.6 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 5.4 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 2.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 1.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 2.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 0.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 0.3 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 1.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 2.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 2.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.1 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.1 | 2.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 1.1 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.1 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.1 | 1.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 12.4 | GO:0042393 | histone binding(GO:0042393) |
| 0.1 | 1.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.1 | 0.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.3 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.1 | 1.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 2.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.1 | 0.6 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.1 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 0.2 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
| 0.1 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.1 | 0.9 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 0.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 1.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 2.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 0.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.1 | 1.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 1.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 0.9 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.1 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 1.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.1 | 2.4 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
| 0.1 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.1 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 4.5 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.1 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 1.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 43.7 | GO:0003677 | DNA binding(GO:0003677) |
| 0.1 | 1.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
| 0.1 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 0.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 1.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 8.5 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 2.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.1 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 1.4 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 1.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.1 | 3.5 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.1 | 0.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
| 0.1 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.1 | 0.5 | GO:0030547 | receptor inhibitor activity(GO:0030547) acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.1 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.1 | 2.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.1 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.1 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.1 | 0.2 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 1.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.1 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 1.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.1 | 0.2 | GO:0052740 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.1 | 1.1 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
| 0.1 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.1 | 0.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
| 0.1 | 3.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.4 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.1 | 1.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 5.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
| 0.1 | 0.1 | GO:0004043 | L-aminoadipate-semialdehyde dehydrogenase activity(GO:0004043) |
| 0.1 | 0.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.0 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 2.0 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 1.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.2 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.0 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.0 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.0 | 1.8 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.0 | 35.5 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.0 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.0 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.0 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.4 | GO:0071949 | FAD binding(GO:0071949) |
| 0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.0 | 0.1 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.0 | 1.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.0 | 0.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
| 0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 1.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.0 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 5.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.0 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 1.5 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.0 | 0.1 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.5 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.0 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.0 | 0.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.1 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.0 | 0.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
| 0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.0 | 0.1 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
| 0.0 | 0.5 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
| 0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.0 | 0.0 | GO:0070905 | serine binding(GO:0070905) |
| 0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.0 | 0.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.0 | 0.0 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.0 | 0.1 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.0 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.0 | 0.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.0 | 0.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.0 | 0.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.6 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.0 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.1 | GO:0003823 | antigen binding(GO:0003823) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 0.7 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
| 0.5 | 34.1 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.4 | 3.3 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 16.0 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 0.4 | 23.3 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.3 | 1.4 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.3 | 16.6 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.3 | 9.5 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 1.5 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 6.3 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 0.3 | 7.4 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 0.2 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 6.8 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.2 | 6.1 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 1.6 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.2 | 3.1 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 0.4 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 1.1 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 2.6 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 5.9 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 2.6 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.2 | 0.8 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 2.9 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.2 | 3.3 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.2 | 3.0 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 0.4 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 8.6 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
| 0.2 | 4.5 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
| 0.2 | 0.7 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 0.2 | 3.3 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 4.8 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.2 | 15.6 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.2 | 7.5 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 1.2 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 2.2 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.1 | 4.3 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
| 0.1 | 1.2 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 0.6 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 3.0 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 2.6 | PID_IGF1_PATHWAY | IGF1 pathway |
| 0.1 | 1.2 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
| 0.1 | 0.8 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.1 | 4.5 | NABA_COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 0.5 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.1 | 4.9 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 1.4 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.1 | 1.6 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.1 | 3.4 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 4.9 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 1.0 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.1 | 12.0 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 2.8 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
| 0.1 | 0.4 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 0.5 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 0.8 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 0.4 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 1.8 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 0.4 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 0.9 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 2.6 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.1 | 1.3 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
| 0.1 | 0.1 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 0.2 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 4.2 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.1 | 1.1 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.1 | 0.3 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.8 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.8 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.0 | 2.2 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 1.5 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.6 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 5.9 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.7 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 0.3 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.0 | 0.1 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.2 | ST_GA13_PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.4 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 1.4 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.0 | 0.1 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 1.1 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.1 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.0 | 1.3 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.0 | 0.3 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 0.1 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.1 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.2 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.0 | 0.2 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.8 | PID_CDC42_PATHWAY | CDC42 signaling events |
| 0.0 | 0.4 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.0 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 0.1 | PID_AVB3_INTEGRIN_PATHWAY | Integrins in angiogenesis |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 1.4 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 1.0 | 6.3 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 1.0 | 1.9 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.6 | 5.1 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 0.6 | 4.4 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
| 0.5 | 6.5 | REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.5 | 52.8 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.5 | 1.0 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.5 | 12.7 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.4 | 7.6 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.4 | 2.2 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.4 | 7.2 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.4 | 4.2 | REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.4 | 1.2 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.4 | 3.3 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.4 | 9.4 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 0.4 | 3.9 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.4 | 2.6 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.4 | 5.9 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.4 | 1.8 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.4 | 9.2 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.3 | 2.3 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.3 | 2.8 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.3 | 8.4 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.3 | 2.1 | REACTOME_INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 6.0 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.3 | 7.2 | REACTOME_DOUBLE_STRAND_BREAK_REPAIR | Genes involved in Double-Strand Break Repair |
| 0.3 | 1.1 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 5.9 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.2 | 0.2 | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | Genes involved in Cytokine Signaling in Immune system |
| 0.2 | 1.5 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 4.1 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.2 | 2.9 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.2 | 2.4 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 2.3 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 2.2 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.2 | 2.0 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 2.6 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.2 | 2.6 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 1.9 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 2.7 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.2 | 2.3 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 10.0 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
| 0.2 | 0.8 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 2.0 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.2 | 3.4 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 0.2 | 1.6 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.2 | 1.0 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.2 | 1.3 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.2 | 0.7 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.2 | 2.2 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.2 | 4.9 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 4.7 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.2 | 1.2 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 5.5 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 1.8 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 3.9 | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.2 | 2.9 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 3.2 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.2 | 1.5 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 2.0 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.1 | 3.0 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.1 | 1.9 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 3.2 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 1.0 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 0.3 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
| 0.1 | 1.1 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 1.5 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 2.3 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 3.1 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 1.0 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 1.5 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 7.9 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 7.2 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.1 | 0.6 | REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER | Genes involved in Transcription-coupled NER (TC-NER) |
| 0.1 | 1.2 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 4.8 | REACTOME_MRNA_3_END_PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.1 | 0.9 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 0.4 | REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.1 | 0.4 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 0.8 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 0.5 | REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.1 | 0.7 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 1.7 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 5.1 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 4.7 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 0.7 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 0.8 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 0.7 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 0.2 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.1 | 1.3 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 0.5 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 1.6 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.2 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 0.2 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 1.7 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 0.9 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 0.7 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 3.0 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 5.9 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.9 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 1.0 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 1.0 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 1.7 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 1.0 | REACTOME_ZINC_TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 1.0 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 0.5 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 0.3 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 1.2 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 1.4 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 1.8 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.4 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 0.9 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 0.5 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.5 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.4 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.0 | 0.6 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 0.3 | REACTOME_CHROMOSOME_MAINTENANCE | Genes involved in Chromosome Maintenance |
| 0.0 | 1.0 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 0.1 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.0 | 1.6 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
| 0.0 | 0.5 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.9 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.4 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.0 | 0.2 | REACTOME_OLFACTORY_SIGNALING_PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.3 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.4 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.5 | REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.0 | 0.1 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 0.2 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.2 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.1 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 0.6 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.4 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.1 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.0 | 0.6 | REACTOME_APOPTOTIC_EXECUTION_PHASE | Genes involved in Apoptotic execution phase |
| 0.0 | 0.1 | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.0 | 0.0 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 0.1 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.3 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.0 | 0.2 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
|
|
|